Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier

Bentham, Peter; Staff, Roger T.; Schelter, Bjoern O.; Shiells, Helen; Harrington, Charles R.; Wischik, Claude M.

Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier

Files

Bentham_et_al_Long_term_Journal_of_alzheimers_disease_vor.pdf (905.09 KB)

Date

2021-09-28

Authors

Harrington, Charles R.

Wischik, Claude M.

Citation

Bentham, P, Staff, R T, Schelter, B O, Shiells, H, Harrington, C R & Wischik, C M 2021, 'Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier', Journal of Alzheimer's Disease, vol. 83, no. 3, pp. 1017-1023. https://doi.org/10.3233/JAD-210390